Study supports drug-eluting stents for STEMI patients

08/19/2013 | TCTMD.com

Drug-eluting stents beat bare-metal stents for reducing target vessel revascularization without raising the risk of stent thrombosis in STEMI patients, according to a meta-analysis published in Circulation: Cardiovascular Interventions. Researchers analyzed data from clinical trials involving 14,740 STEMI patients. "The totality of data with results from cohorts, including non-acute coronary syndrome patients, patients with diabetes mellitus, and now patients with STEMI, suggest that DES (especially EES) should be the benchmark for both efficacy and safety for future clinical trials," the authors wrote.

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ